Rivastigmine Medications

Rivastigmine is a cholinesterase inhibitor used to manage symptoms of Alzheimer's and Parkinson's dementia by elevating acetylcholine in the brain.

Exelon

Rivastigmine

$0.77 per pill

1.5 | 3mg

Select pack

Rivastigmine Information

Rivastigmine is a reversible cholinesterase inhibitor prescribed for the symptomatic treatment of dementia associated with Alzheimer’s disease and Parkinson’s disease. Belonging to the class of acetylcholinesterase inhibitors, it increases synaptic acetylcholine by blocking the enzymes acetylcholinesterase and butyrylcholinesterase. Commercially, Rivastigmine is available as oral capsules, tablets, and a transdermal patch, marketed under brand names such as Exelon® and listed as generic Rivastigmine. While its primary indication covers mild-to-moderate dementia, clinicians sometimes explore off-label applications for Lewy-body dementia where cholinergic deficits are evident. Understanding its pharmacology, therapeutic window, and safety profile is essential for patients and caregivers navigating dementia care.

What is Rivastigmine?

Rivastigmine is a centrally acting reversible acetylcholinesterase and butyrylcholinesterase inhibitor. The Health Sciences Authority (HSA) of Singapore approved the drug in 2005 for the treatment of Alzheimer’s disease dementia, later extending the indication to Parkinson’s disease dementia. The United States FDA first authorized Rivastigmine in 200, and the European Medicines Agency (EMA) granted marketing authorization in 2001. By inhibiting the breakdown of acetylcholine, Rivastigmine enhances cholinergic neurotransmission, which is typically depleted in neurodegenerative dementias. Both the oral formulation (capsules, tablets) and the 4.6 mg/24 h transdermal patch are listed on Singapore’s National Medicines Register and can be sourced through our online pharmacy as generic or branded versions.

How Rivastigmine Works

Mechanism of Action

Rivastigmine binds to the active sites of acetylcholinesterase and butyrylcholinesterase, forming a carbamylated complex that reversibly deactivates the enzymes. This blockade slows acetylcholine hydrolysis, allowing higher concentrations of the neurotransmitter to persist in synaptic clefts throughout the cerebral cortex and hippocampus. The dual inhibition distinguishes Rivastigmine from agents that target acetylcholinesterase alone, potentially offering broader cholinergic support.

Therapeutic Effects

Enhanced cholinergic signaling translates into modest improvements in cognition, activities of daily living, and global clinical status for patients with dementia. Clinical scales such as the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) have demonstrated average gains of 2-3 points after 24 weeks of therapy, reflecting slowed deterioration rather than reversal of disease.

Onset and Duration

Therapeutic benefits typically emerge within 4-6 weeks of initiating treatment, with peak effects observed around 12 weeks. The oral dosage requires twice-daily administration to maintain steady plasma levels, while the transdermal patch delivers a constant release over 24 hours, reducing peak-trough fluctuations. The half-life of Rivastigmine is approximately 1.5 hours for the oral form and 3 hours for the patch, but clinical effect persists as long as the enzyme inhibition is maintained.

Approved Uses and Applications

Approved Indications

Alzheimer’s disease dementia: Mild-to-moderate stages, as defined by Mini-Mental State Examination (MMSE) scores of 10-26.
Parkinson’s disease dementia: Symptomatic management of cognitive decline in patients with established Parkinsonism. These indications are endorsed by the HSA, the FDA, and the EMA, with prescribing information emphasizing titration to the optimal dose based on tolerability.

Off-Label Uses

Rivastigmine has been investigated for Lewy-body dementia and for cognitive symptoms in vascular dementia. While some open-label studies suggest modest benefit, regulatory agencies have not granted formal approval for these conditions, so clinicians must weigh evidence against the lack of official endorsement.

Clinical Efficacy

A pivotal randomized, double-blind trial published in The New England Journal of Medicine reported a 4.6-point advantage on the ADAS-Cog for patients receiving Rivastigmine versus placebo after 24 weeks (p < .001). Long-term extensions indicated that continuation of therapy delayed institutionalization by up to 12 months compared with untreated cohorts. Real-world data from Singaporean memory clinics echo these findings, demonstrating a 15 % slower rate of MMSE decline over one year in patients adherent to Rivastigmine therapy.

Buying Rivastigmine from Our Online Pharmacy

Why Choose Our Service

Access to dementia medications can be limited by pharmacy stock or insurance formularies. Our online pharmacy bridges that gap, offering discreet, reliable delivery of both brand-name Exelon® and high-quality generic Rivastigmine. By sourcing from licensed international partners that comply with WHO Good Manufacturing Practices, we ensure each shipment meets strict safety standards.

Brand Names and Generic Options

Exelon® transdermal patch (4.6 mg/24 h)
Exelon® oral capsules (1.5 mg, 3 mg)
Rivastigmine generic tablets (1.5 mg, 3 mg, 4.5 mg)
Rivastigmine oral solution (2 mg/mL) Choosing the generic formulation typically reduces cost by 30-45 % without compromising efficacy, making it a practical option for long-term management.

Quality & Safety

Our pharmacy service works with verified partners operating under regulatory frameworks recognized by the HSA and the International Council for Harmonisation. Every product undergoes authenticity checks and temperature-controlled shipping.

Pricing & Access

Competitive pricing is displayed at checkout, and a Lifetime 10 % discount on all reorders rewards ongoing patients. For those searching to buy Rivastigmine online, the transparent price breakdown includes medication cost, shipping, and any applicable duties.

Discreet Delivery

Orders ship via an unmarked parcel; express delivery averages 7 days, while standard service arrives within 3 weeks. Packaging is insulated and tamper-evident, protecting potency throughout transit.

Dosing, Formulations & Administration

Available Formulations

Oral capsules/tablets: 1.5 mg, 3 mg, 4.5 mg strengths.
Transdermal patch: 4.6 mg/24 h (delivered over a 24-hour period).
Oral solution: 2 mg/mL for patients with swallowing difficulties.

Typical Dosing Ranges

For adults with Alzheimer’s disease, clinicians often start with 1.5 mg twice daily (or a 4.6 mg/24 h patch) and titrate upward every 2-4 weeks to a target of 6 mg twice daily or a 9.5 mg/24 h patch, depending on tolerability. In Parkinson’s disease dementia, similar titration is used, with adjustments for motor symptom interactions. The exact dose must be individualized by a healthcare professional who considers renal and hepatic function, concomitant medications, and adverse-effect profile.

Administration Guidelines

Oral form: Take with food to lessen gastrointestinal irritation. Swallow tablets whole; do not crush or chew.
Patch: Apply to clean, dry, hair-free skin on the upper back or upper arm. Rotate sites daily to avoid local skin irritation and change every 24 hours.
Solution: Measure with a calibrated oral syringe; administer with or without food.

A qualified clinician determines the final regimen, ensuring the balance between cognitive benefit and side-effect risk.

Safety Profile & Considerations

Common Side Effects

Nausea (≈20 % of patients)
Vomiting (≈12 %)
Diarrhea (≈10 %)
Loss of appetite (≈9 %)
Dizziness or light-headedness (≈8 %)

These events are often dose-related and may improve with gradual titration.

Serious Adverse Events

Rare but clinically important risks include:

Bradycardia or heart block: May present as syncope; immediate medical evaluation required.
Gastrointestinal bleeding: Particularly in patients on anticoagulants or antiplatelet agents.
Severe skin reactions with the patch (e.g., contact dermatitis, urticaria).

Contraindications

Known hypersensitivity to Rivastigmine or any excipients.
Severe hepatic impairment (Child-Pugh C).
Active gastrointestinal obstruction, ulceration, or severe constipation.
Patients with unstable cardiac conduction disorders.

Drug Interactions

Anticholinergic agents (e.g., diphenhydramine, oxybutynin) may blunt Rivastigmine’s cognitive benefits.
Concurrent cholinesterase inhibitors (e.g., donepezil, galantamine) increase risk of cholinergic toxicity.
Beta-blockers and calcium channel blockers can exacerbate bradycardia.
Non-steroidal anti-inflammatory drugs (NSAIDs) heighten gastrointestinal bleeding risk.

Special Populations

Pregnancy & Breastfeeding: Safety not established; use only if potential benefit outweighs risk.
Elderly: Dose adjustments may be needed for reduced hepatic clearance.
Renal impairment: No dose reduction required for mild to moderate renal dysfunction, but caution in severe cases.
Hepatic dysfunction: Initiate at the lowest dose and titrate slowly; monitor liver enzymes.

Always discuss medical history, current medications, and any comorbid conditions with a healthcare provider before starting Rivastigmine.

Frequently Asked Questions

How does Rivastigmine differ from donepezil? Rivastigmine inhibits both acetylcholinesterase and butyrylcholinesterase, whereas donepezil selectively targets acetylcholinesterase. This broader inhibition may offer modest advantages in certain dementia subtypes, but comparative trials show similar overall efficacy.
How long does Rivastigmine take to work? Patients generally notice cognitive stabilization after 4-6 weeks, with maximal observable benefit around 12 weeks of consistent therapy.
Can I switch from oral Rivastigmine to the patch? Yes; the patch provides a smoother plasma concentration and may reduce gastrointestinal side effects. Conversion requires a calculated dose equivalence and should be overseen by a clinician.
What foods should I avoid while taking Rivastigmine? No specific foods are prohibited, but taking the medication with meals can lessen nausea. Avoid excess alcohol, which may increase dizziness.
What should I do if I experience persistent nausea? Report the symptom to your prescriber. They may lower the dose, slow the titration schedule, or suggest anti-emetic therapy.
Is the transdermal patch safe for patients with skin allergies? Most reactions are mild erythema. If severe dermatitis develops, discontinue the patch and discuss alternative formulations with your doctor.
How does Rivastigmine affect blood pressure? It has no direct antihypertensive effect, but bradycardia can lead to transient drops in blood pressure, especially in patients on beta-blockers.
What are the long-term safety considerations? Chronic use is associated with sustained gastrointestinal side effects and a small increase in the risk of weight loss. Regular monitoring of weight, nutritional status, and liver function is recommended.
Can I take Rivastigmine while on antidepressants? Most antidepressants are safe, but selective serotonin reuptake inhibitors (SSRIs) that also possess anticholinergic properties may diminish cognitive benefit. Coordination with a mental-health professional is advisable.
What information should I provide my doctor when discussing Rivastigmine?
- Complete list of current prescription and over-the-counter medications, including supplements.
- History of cardiac conditions, especially arrhythmias or heart block.
- Any gastrointestinal disorders such as ulcers or chronic constipation.
- Current cognitive assessment scores (e.g., MMSE) and specific goals for treatment.

Disclaimer

The information provided about Rivastigmine is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing Rivastigmine for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing Rivastigmine.